These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23562060)

  • 1. Discovery of ML326: The first sub-micromolar, selective M5 PAM.
    Gentry PR; Bridges TM; Lamsal A; Vinson PN; Smith E; Chase P; Hodder PS; Engers JL; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    Bioorg Med Chem Lett; 2013 May; 23(10):2996-3000. PubMed ID: 23562060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and Optimization of Potent and CNS Penetrant M
    Bender AM; Cho HP; Nance KD; Lingenfelter KS; Luscombe VB; Gentry PR; Voigtritter K; Berizzi AE; Sexton PM; Langmead CJ; Christopoulos A; Locuson CW; Bridges TM; Chang S; O'Neill JC; Zhan X; Niswender CM; Jones CK; Conn PJ; Lindsley CW
    ACS Chem Neurosci; 2018 Jul; 9(7):1572-1581. PubMed ID: 29678111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): the development of ML169, an MLPCN probe.
    Reid PR; Bridges TM; Sheffler DJ; Cho HP; Lewis LM; Days E; Daniels JS; Jones CK; Niswender CM; Weaver CD; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2011 May; 21(9):2697-701. PubMed ID: 21194936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.
    Bridges TM; Kennedy JP; Hopkins CR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5617-22. PubMed ID: 20801651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of the first M5-selective and CNS penetrant negative allosteric modulator (NAM) of a muscarinic acetylcholine receptor: (S)-9b-(4-chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375).
    Gentry PR; Kokubo M; Bridges TM; Kett NR; Harp JM; Cho HP; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Wood MR; Lindsley CW
    J Med Chem; 2013 Nov; 56(22):9351-5. PubMed ID: 24164599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.
    Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3189-93. PubMed ID: 24856064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part II: development of a potent and highly selective M1 PAM.
    Bridges TM; Phillip Kennedy J; Noetzel MJ; Breininger ML; Gentry PR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1972-5. PubMed ID: 20156687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and structure-activity relationships study of positive allosteric modulators of the M
    Tanaka H; Negoro K; Koike T; Tsukamoto I; Yokoyama K; Maeda J; Inagaki Y; Shimoshige Y; Ino K; Ishizu K; Takahashi T
    Bioorg Med Chem; 2020 Jul; 28(13):115531. PubMed ID: 32386953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.
    Bridges TM; Marlo JE; Niswender CM; Jones CK; Jadhav SB; Gentry PR; Plumley HC; Weaver CD; Conn PJ; Lindsley CW
    J Med Chem; 2009 Jun; 52(11):3445-8. PubMed ID: 19438238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition.
    Wood MR; Noetzel MJ; Tarr JC; Rodriguez AL; Lamsal A; Chang S; Foster JJ; Smith E; Chase P; Hodder PS; Engers DW; Niswender CM; Brandon NJ; Wood MW; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4282-6. PubMed ID: 27476142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery, synthesis and characterization of a highly muscarinic acetylcholine receptor (mAChR)-selective M5-orthosteric antagonist, VU0488130 (ML381): a novel molecular probe.
    Gentry PR; Kokubo M; Bridges TM; Cho HP; Smith E; Chase P; Hodder PS; Utley TJ; Rajapakse A; Byers F; Niswender CM; Morrison RD; Daniels JS; Wood MR; Conn PJ; Lindsley CW
    ChemMedChem; 2014 Aug; 9(8):1677-82. PubMed ID: 24692176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354.
    Wen W; Young SE; Duvernay MT; Schulte ML; Nance KD; Melancon BJ; Engers J; Locuson CW; Wood MR; Daniels JS; Wu W; Lindsley CW; Hamm HE; Stauffer SR
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4708-4713. PubMed ID: 25176330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further optimization of the M5 NAM MLPCN probe ML375: tactics and challenges.
    Kurata H; Gentry PR; Kokubo M; Cho HP; Bridges TM; Niswender CM; Byers FW; Wood MR; Daniels JS; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2015 Feb; 25(3):690-4. PubMed ID: 25542588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of VU0486846: steep SAR from a series of M
    Bertron JL; Cho HP; Garcia-Barrantes PM; Panarese JD; Salovich JM; Nance KD; Engers DW; Rook JM; Blobaum AL; Niswender CM; Stauffer SR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2175-2179. PubMed ID: 29754948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-exploration of the mGlu₁ PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SAR.
    Garcia-Barrantes PM; Cho HP; Starr TM; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 May; 26(9):2289-92. PubMed ID: 27013388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a novel, CNS penetrant M
    Bewley BR; Spearing PK; Weiner RL; Luscombe VB; Zhan X; Chang S; Cho HP; Rodriguez AL; Niswender CM; Conn PJ; Bridges TM; Engers DW; Lindsley CW
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4274-4279. PubMed ID: 28866269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spirocyclic replacements for the isatin in the highly selective, muscarinic M1 PAM ML137: the continued optimization of an MLPCN probe molecule.
    Poslusney MS; Melancon BJ; Gentry PR; Sheffler DJ; Bridges TM; Utley TJ; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Wood MR
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1860-4. PubMed ID: 23416001
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.